Obesity management has undergone a major transformation, with newer pharmacological therapies reshaping clinical practice. As evidence for incretin-based therapies, combination agents, and next-generation molecules rapidly evolve, clinicians are seeking clarity on how to apply these advances safely and effectively in everyday care.

In this session, we explore the latest trends in obesity pharmacotherapy—mechanisms, indications, real-world outcomes, and practical considerations for patient selection. Dr Abhishek will share clear insights about the emerging treatment landscape and how these newer drugs can be integrated into holistic, long-term obesity management strategies.